Utah Medical Products (NASDAQ:UTMD) Full Year 2023 ResultsKey Financial Results Revenue: US$50.2m (down 3.9% from FY 2022). Net income: US$16.6m (up 1.0% from FY 2022). Profit margin: 33% (up from 32%...
Source LinkUtah Medical Products (NASDAQ:UTMD) Full Year 2023 ResultsKey Financial Results Revenue: US$50.2m (down 3.9% from FY 2022). Net income: US$16.6m (up 1.0% from FY 2022). Profit margin: 33% (up from 32%...
Source Link
Comments